Ergoteles LLC Lensar, Inc. Transaction History

Ergoteles LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$5.8 - $8.2 $116,232 - $164,328	-20,040 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$5.9 - $7.84 $62,994 - $83,707	-10,677 Reduced 34.76%	20,040 $119,000
Q3 2021 Nov 15, 2021	SELL	$7.5 - $8.88 $1,477 - $1,749	-197 Reduced 0.64%	30,717 $242,000
Q2 2021 Aug 12, 2021	BUY	$6.87 - $8.66 $212,379 - $267,715	30,914 New	30,914 $268,000

4.91M

700

31.3K

Ticker LNSR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 11,021,000
Market Cap $96.4M
Description
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.